European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 420-423 , May 2007

The significance of the site of recurrence to subsequent breast cancer survival

,Accepted 6 September 2006.

References 

  1. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97(3):545–553
  2. Vogel CL, Azevedo S, Hilsenbeck S, East DR, Ayub J. Survival after first recurrence of breast cancer. The Miami experience. Cancer. 1992;70(1):129–135
  3. Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998;77(2):336–340
  4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) . Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717
  5. Rabinovich M, Vallejo C, Bianco A, et al. Development and validation of prognostic models in metastatic breast cancer: a GOCS study. Oncology. 1992;49(3):188–195
  6. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat. 1999;56(1):67–78
  7. Pater JL, Mores D, Loeb M. Survival after recurrence of breast cancer. Can Med Assoc J. 1981;124(12):1591–1595
  8. Clark GM, Sledge GW, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987;5(1):55–61
  9. Kamby C, Sengelov L. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res Treat. 1997;45(2):181–192
  10. Curcio LD, Chu DZ, Ahn C, et al. Local recurrence in breast cancer: implications for systemic disease. Ann Surg Oncol. 1997;4(1):24–27
  11. Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ. Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat. 1992;21(3):173–180
  12. Giordano HS, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving?. Cancer. 2004;100(1):44–52
  13. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000;59(3):271–278
  14. Perez JE, Machiavelli M, Leone BA, et al. Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. Grupo Oncologica Cooperativo del Sur. Am J Clin Oncol. 1990;13(4):294–298
  15. Ahmann FR, Jones SE, Moon TE. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Surg Oncol. 1988;37(2):116–122
  16. Buckner JC, Ingle JN, Everson LK, et al. Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer. Breast Cancer Res Treat. 1989;13(2):135–142
  17. Dittrich C, Jakesz R, Pirich K, et al. Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer. J Cancer Res Clin Oncol. 1987;113(5):488–494
  18. Houston SJ, Richards MA, Bentley AE, Smith P, Rubens RD. The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer. Eur J Cancer. 1993;29A(11):1513–1518
  19. Castiglione-Gertsch M, Tattersall M, Hacking A, et al. Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group. Eur J Cancer. 1997;33(14):2321–2325

PII: S0748-7983(06)00328-3

doi: 10.1016/j.ejso.2006.09.005

European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 420-423 , May 2007

Article Tools

* Image Usage & Resolution